Results 121 to 130 of about 16,720 (208)

Gypenosides inhibit melanoma proliferation, migration and enhance the anti-tumor immunity of CD8⁺ T cells via ETV5/PD-L1 signaling. [PDF]

J Transl Med
Yin Y, Lai W, Hu C, Zhou H, Liu Y, Liu Y, Yang M, He K, Li G.   +8 more
europepmc   +1 more source

Effects of Arylsulfatase B and Pembrolizumab in combination on progression of metastatic melanoma in the B16F10 syngeneic mouse model. [PDF]

Front Oncol
Bhattacharyya S, O-Sullivan I, Tobacman JK.   +2 more
europepmc   +1 more source

TMEM87A suppresses ferroptosis and increases cancer immunotherapy resistance by maintaining the Golgi apparatus pH homeostasis. [PDF]

Nat Cancer
Li J, Zhou Y, Li X, Yin S, Gao Y, Shang H, Lai Y, Yang L, Xue Y, Li X, Li Y, Chang Z, Chen J, Cheng X, Zhang X, Chu Q, Lu F, Wang W.   +17 more
europepmc   +1 more source

Adherent-to-suspension transition modulates circulating tumor cell dynamics and metastatic potential in melanoma. [PDF]

Mol Cells
Lee DK, Oh J, Lee S, Huh HD, Sub Y, Yoon K, Shin WC, Kim S, Park HW, Gee HY.   +9 more
europepmc   +1 more source

α-MSH Induces Intracellular ROS Generation in Melanoma Cells through NADPH Oxidase-1/4 Activation. [PDF]

Biomol Ther (Seoul)
Kim K, Yoon J, Kim HY, Lim KM.
europepmc   +1 more source

CpG 1018 augments mRNA vaccine-induced anti-tumor immunity by potentiating CD8+ T cell responses. [PDF]

Mol Ther Oncol
Li Y, Nakkala JR, Akter L, Kang X, Song Y, VanLuinen E, Chen X.   +6 more
europepmc   +1 more source

SLC38A4 promotes Kupffer cell phagocytosis and suppresses tumor liver metastasis. [PDF]

Exp Mol Med
Li J, Liu YD, Wang R, Lin XY, Zhu YQ, Lu WP, Tang YF, Guo XP, Ai YH, Xu TT, Lin S, Huang M, Wang J, Zhu XT, Yuan JH.   +14 more
europepmc   +1 more source

Tilapia Skin-Derived Peptide PFRMY Attenuates Melanogenesis and Tyrosinase Activity via α-MSH/PKA/CREB Signaling Pathways in B16F10 Murine Melanoma Cells. [PDF]

Foods
Song Y, Lu C, Chen S, Zhao Y, Huang H, Xiang H, Long X, Hu X.   +7 more
europepmc   +1 more source

Retraction: Chamaejasmin B decreases malignant characteristics of mouse melanoma B16F0 and B16F10 cells. [PDF]

Front Oncol
Editorial Office F.
europepmc   +1 more source

Control of poorly immunogenic tumors with systemic STING agonist-loaded liposomes targeting cross-presenting dendritic cells. [PDF]

Clin Transl Immunology
Zeng B, Talekar M, Aragao-Horoiwa T, Cameron A, Zhao G, Zybina Y, Blumenschein W, van de Mark K, Suwakulsiri W, Baltus GA, Dolcetti R, Thomas R.   +11 more
europepmc   +1 more source